Watford, United Kingdom

James Jun Bon Mui

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Jun Bon Mui: Innovator in Pain Treatment

Introduction

James Jun Bon Mui is a notable inventor based in Watford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for pain treatment. His innovative work has the potential to impact the lives of many individuals suffering from various disorders.

Latest Patents

James Jun Bon Mui holds a patent for "Heteroaryl compounds for the treatment of pain." This patent includes compounds and pharmaceutically acceptable salts that serve as inhibitors of sodium channels. The patent also outlines pharmaceutical compositions that incorporate these compounds and methods for their use in treating disorders, including pain.

Career Highlights

James is currently employed at Vertex Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Vertex has positioned him as a key player in the pharmaceutical industry, focusing on innovative solutions for pain management.

Collaborations

James collaborates with various professionals in his field, including his coworker Dennis James Hurley. Their combined expertise contributes to the ongoing development of effective treatments for pain and related disorders.

Conclusion

James Jun Bon Mui's contributions to the field of pain treatment through his innovative compounds and collaborations highlight his importance as an inventor. His work at Vertex Pharmaceuticals, Inc. continues to pave the way for advancements in pharmaceutical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…